Entecavir plus adefovir versus adefovir plus lamivudine in hepatitis B virus e antigen-positive, lamivudine-resistant chronic hepatitis B-Reference-Cited by-同舟云学术

Entecavir plus adefovir versus adefovir plus lamivudine in hepatitis B virus e antigen-positive, lamivudine-resistant chronic hepatitis B

Published:2014-07 Issue:7 Volume:29 Page:1485-1493
ISSN:0815-9319
Container-title:Journal of Gastroenterology and Hepatology
language:en
Short-container-title:J Gastroenterol Hepatol

Author:

Heo Jeong¹,Ahn Sang Hoon²,Kweon Young-Oh³,Kim Byung-Ho⁴,Chan Henry L Y⁵,Horban Andrzej⁶⁷,Wongcharatrawee Suchat⁸,Llamoso Cyril⁹,Lee Kwan Sik²

Affiliation:

1. Department of Internal Medicine; Pusan National University School of Medicine and Medical Research Institute; Pusan National University Hospital; Pusan Korea

2. Yonsei University College of Medicine; Seoul Korea

3. The Kyungpook National University Hospital; Daegu Korea

4. Kyung Hee University Hospital; Seoul Korea

5. The Chinese University of Hong Kong; Hong Kong China

6. Warsaw Medical University; Warsaw Poland

7. Hospital of Infectious Diseases; Warsaw Poland

8. Bristol-Myers Squibb; Shanghai China

9. Bristol-Myers Squibb; Wallingford Connecticut USA

Funder

Bristol-Myers Squibb

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jgh.12567/fullpdf

Reference46 articles.

1. Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update;Liaw;Hepatol. Int.,2012

2. Chronic hepatitis B: update 2009;Lok;Hepatology,2009

3. EASL clinical practice guidelines: management of chronic hepatitis B virus infection;European Association for the Study of the Liver;J. Hepatol.,2012

4. Adefovir-resistant hepatitis B can be associated with viral rebound and hepatic decompensation;Fung;J. Hepatol.,2005

5. Lamivudine for patients with chronic hepatitis B and advanced liver disease;Liaw;N. Engl. J. Med.,2004

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and cost-effectiveness of antiviral regimens for entecavir-resistant hepatitis B: A systematic review and network meta-analysis;Hepatobiliary & Pancreatic Diseases International;2020-12

2. Tenofovir disoproxil fumarate monotherapy is superior to entecavir-adefovir combination therapy in patients with suboptimal response to lamivudine-adefovir therapy for nucleoside-resistant HBV: a 96-week prospective multicenter trial;Antiviral Therapy;2017

3. Prediction of virologic response to tenofovir mono-rescue therapy for multidrug resistant chronic hepatitis B;Journal of Medical Virology;2015-11-19